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Abstract  
We have previously demonstrated that acute stress decreases neuronal nitric oxide synthase (NOS) 
expression in the hippocampus despite increased concentrations of nitric oxide which may indicate 
feedback inhibition of neuronal NOS expression via inducible NOS-derived nitric oxide. Moreover, 
the hippocampus undergoes an initial oxidative/nitrosative insult that is rapidly followed by 
upregulation of protective antioxidants, including the zinc-binding metallothioneins, in order to 
counter this and restore redox balance following acute stress exposure. In the present study, we 
have utilized indicators of oxidative/nitrosative stress, members of the nuclear factor (erythroid-
derived 2)-like 2 (Nrf2) pathway, antioxidant metallothioneins, and neuroinflammatory markers to 
observe the changes occurring in the hippocampus following short term repeated stress exposure. 
Male Wistar rats were subjected to control conditions or 6 hours of restraint stress applied for 1, 2, 
or 3 days (n=8 per group) after which the hippocampus was isolated for redox assays and relative 
gene expression. The hippocampus showed increased oxidative stress, transient dys-homeostasis of 
total zinc, and increased expression of the Nrf2 pathway members. Moreover, repeated stress 
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increased nitrosative status, nitric oxide metabolites, and 3-nitrotyrosine, indicative of nitrosative 
stress in the hippocampus. However, levels of neuronal NOS decreased over all stress treatment 
groups, while increases were observed in inducible NOS and xanthine dehydrogenase. In addition 
to inducible NOS, mRNA expression of other inflammatory markers including interleukin-6 and 
interleukin-1β also increased even in the presence of increased anti-inflammatory glucocorticoids. 
Together, these results demonstrate that despite increases in antioxidant expression, sub-acute stress 
causes an inflammatory phenotype in the hippocampus by inducing oxidative/nitrosative stress, zinc 
dys-homeostasis, and the accumulation of nitrotyrosinated proteins which is likely driven by 
increased inducible NOS signaling. 
Keywords: hippocampus; neuroinflammatory response; nitrosative stress; oxidative stress; redox 
status; restraint stress; zinc 
 
Abbreviations:  
3-NT, 3-nitrotyrosine; ARE, antioxidant response element; DAF-FM DA,  4-amino-5-
methylamino-2′, 7′-difluorofluorescein diacetate; DCF, dichloroﬂuorescein; DCFH-DA, 2', 7'-
dichlorodihydrofluorescein diacetate; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; GSH, 
reduced glutathione; Hmox1, heme oxygenase 1; Keap1, Kelch-like ECH-associated protein 1; Mif, 
macrophage migration inhibitory factor; MHC, major histocompatibility complex; Mt1a, 
metallothionein 1a; NF-κB, nuclear factor kappa-light-chain-enhancer of activated B cells; NO, 
nitric oxide; NOS, nitric oxide synthase; Nos1ap, nitric oxide synthase adaptor protein; Nqo1, 
NAD(P)H dehydrogenase, quinone 1; Nrf2, nuclear factor (erythroid-derived 2)-like 2; Xdh, 
xanthine dehydrogenase.  
 
Introduction 
The endocrine and biochemical changes that occur following short-term stress exposure contribute 
to a number of physiological and behavioral adaptations intended to protect the individual from 
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further insult. Initially, this is mediated by stress hormones released from the adrenal gland, 
including corticosterone, which act as long-range effectors of the hypothalamic-pituitary-adrenal 
axis [1]. Both short and prolonged increases in glucocorticoids alter the expression of cellular 
antioxidant gene expression in addition to modulating cellular respiration, resulting in production of 
reactive oxygen and nitrogen species [2]. During acute stress, this results in an initial oxidative 
insult in tissues susceptible to oxidative damage such as the hippocampus. However, we have 
recently demonstrated that this initial oxidative event is countered in this region by decreased 
expression of cellular oxidant generators and increased expression of protective antioxidants 
including members of the glutathione peroxidase family and the cysteine-rich zinc-binding protein, 
metallothionein [3]. Interestingly, zinc which can function as an antioxidant and anti-inflammatory 
agent, has been shown to act as a second messenger along with nitric oxide (NO) to signal oxidative 
imbalance to the specialized sensor, Kelch-like ECH-associated protein 1 (Keap1) [4, 5]. In the 
absence of oxidative challenge, this repressor protein keeps the nuclear factor (erythroid-derived 2)-
like 2 (Nrf2) sequestered in the cytosol. However, in a pro-oxidative environment, Nrf2 is released 
for nuclear translocation [6]. This ultimately leads to the activation of Nrf2-antioxidant response 
element (ARE) signaling which regulates the basal and inducible expression of a variety of 
cytoprotective genes. These downstream targets include the antioxidative enzymes NAD(P)H 
dehydrogenase, quinone 1 (Nqo1) and heme oxygenase 1 (Hmox1) [7-9]. The cytosolic Nqo1 
enzyme catalyzes the detoxification of quinones and its derivatives while the inducible Hmox1 
catalyzes the metabolism of pro-oxidant heme to antioxidants carbon monoxide and biliverdin [10]. 
Another active heme oxygenase isoform, Hmox2, catalyzes the same reaction and is constitutively 
expressed, selectively concentrated in neurons, and responsive to adrenal glucocorticoids [11, 12].  
A recent wealth of evidence has demonstrated that free radicals, and most notably NO, play a 
crucial role in the regulation of stress effects and may be directly involved in the pathophysiology 
of stress-related disorders [13-17]. Under normal conditions, NO produced by the neuronal isoform 
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of nitric oxide synthase (nNOS) is an important neurotransmitter associated with synaptic plasticity, 
memory formation, and neurotransmitter release [18, 19]. Several studies have demonstrated that 
the binding partner of nNOS, nitric oxide synthase 1 adaptor protein (Nos1ap; also known as C-
terminal PDZ ligand of neuronal nitric oxide synthase or CAPON), plays a novel role in mediating 
nNOS signaling and its interaction with the NMDA receptor [20, 21]. Furthermore, reports have 
identified the expression of Nos1ap is significantly higher in tissue from patients with schizophrenia 
and bipolar disorder with genetic association studies listed Nos1ap as a genetic risk factor for 
psychiatric disorders [22-24]. The inducible form of NOS (iNOS), which has been described in cell 
types including macrophages, astrocytes, and microglia, is upregulated following immunological 
stimuli such as cytokines and is responsible for producing large amounts of NO [25]. Moreover, 
xanthine dehydrogenase (or oxidoreductase; Xdh), is responsible for production of oxygen species 
including superoxide and hydrogen peroxide in addition to catalyzing the reduction of nitrite to NO 
under specific conditions [26, 27]. The high amounts of NO and superoxide anions can then 
combine to generate peroxynitrite, a powerful nitrating agent targeting tyrosine residues bound to 
the backbone of peptides and proteins to form 3-nitrotyrosine (3-NT). Increased levels of 3-NT 
indicative of peroxynitrite formation have been detected in numerous neurodegenerative and stress-
related conditions [28, 29]. 
 
It has been suggested in animal models that increased expression of hippocampal nNOS through 
mineralocorticoid receptor-mediated signaling results in the pathological depressive-like behaviors 
associated with chronic stress [30, 31]. Interestingly, Echeverry and colleagues [32] have 
demonstrated an increase in nNOS-immunoreactive and NADPH-d positive neurons in the dorsal 
dentate gyrus and CA1 regions as early as 5 days of repeated restraint stress. However, in our 
previous study, acute stress results in decreased nNOS expression in the hippocampus, with acute 
production of NO mediated predominately by the inflammatory-related inducible NOS isoform [33, 
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34]. This activation likely depends on nuclear factor kappa-light-chain-enhancer of activated B cells 
(NF-κB) signaling [35]. Furthermore, increased iNOS activity and expression following 2 to 4 
hours of restraint stress was observed alongside an upregulation of pro-inflammatory mediators and 
glial-specific markers including interleukin-6 (Il6), macrophage migration inhibitory factor (Mif), 
and major histocompatibility complex (MHC) class II transactivator (Ciita) [33]. However, it is not 
yet known if hippocampal increases in iNOS and reductions in nNOS are isolated to a single stress 
exposure prior to the pathological adaptations occurring during chronic stress. Therefore, in the 
present study, we have used markers of NO production, protein nitrotyrosination, and iNOS/nNOS 
expression to demonstrate that repeated (sub-acute) stress exposure induces a neuroinflammatory 
phenotype in the hippocampus which is accompanied by zinc dys-homeostasis, increased oxidative 
stress, and transiently increased antioxidant expression. 
 
Materials and Methods  
Experimental animals 
All experimental procedures were approved by The University of Queensland Animal Ethics 
Committee under approval number SBS/456/14/URG and performed in accordance with the 
Australian Code for the Care and Use of Animals for Scientific Purposes. Male Wistar rats (Rattus 
norvegicus) aged 7-8 weeks weighing 298.30 ± 4.09 g were sourced from The University of 
Queensland Biological Resources and housed individually in a colony room within the Australian 
Institute of Biotechnology and Nanotechnology (AIBN) animal facility. The colony room was 
maintained under standard laboratory conditions (22 ± 2
o
C; 55 ± 5% humidity) with a 12:12 hour 
light-dark cycle (lights on at 07.00h) and animals were given ad libitum access to standard rat chow 
and water. Rats were habituated to human handling for 10 min per day over six days prior to 
experimentation. 
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Experimental protocol 
On each experimental day, rats were transported to an experimental room within the same animal 
facility where they were acclimated for one hour prior to any procedures. Rats were randomly 
allocated into treatment groups of no stress (unstressed), acute (1 Day, single time of 6 h) and 
repeated (2 and 3 Days, 6 h/day) from 9.00-15.00h using adjustable wire mesh restrainers (n=8 per 
group). To isolate the effects of restraint, control animals were deprived of food and water for the 6-
hour experimental period. Immediately following each respective treatment, a tail-tip blood sample 
was collected into ice-chilled Eppendorf tube containing heparin (20 IU/mL blood). Rats were 
subsequently overdosed with Pentobarbital Sodium (intraperitoneal injection: Lethabarb, 100 
mg/kg, Virbac, Peakhurst, Australia) and the brain was quickly removed and snap-frozen for 
storage at -80
o
C. Blood samples were centrifuged at 2000 x g and the supernatant plasma was 
collected and stored at -80
o
C for later determination of corticosterone concentrations. Plasma 
glucose was determined using a standard glucometer (FreeStyle Optium Neo, Abbott). Frozen 
brains were sectioned on a cryostat and the hippocampus was isolated on a bed of dry ice and stored 
at -80
o
C for later determination of hippocampal redox status, zinc concentration, total NOx (nitrite 
and nitrate), 3-nitrotyrosine, nNOS protein, and relative gene expression analysis.  
 
Plasma corticosterone measurements 
Corticosterone concentrations were determined using 10 µL of plasma by standard 
radioimmunoassay utilizing ovine anti-rat corticosterone polyclonal antibody (Sapphire Biosciences 
Pty. Ltd.) and tritiated [1,2,6,7-3H]-corticosterone tracer as described in Chen et al., [36]. The intra-
assay coefficient of variation was 4.43%.  
Neural tissue preparation  
Assays of oxidative/nitrosative status and zinc were performed in isolated hippocampal tissues. The 
right hemispheric tissues were homogenized (IKA® Ultra-Turrax® T10) in 10 volumes (w/v) of 
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Tris-HCl (0.1 M, pH=7.4) containing a cocktail of protease inhibitors (S8830, Sigma Aldrich) and 
an aliquot was removed for GSH determination. This separate aliquot was immediately loaded with 
an acidic solution containing 10% trichloroacetic acid (w/v) in 0.1 M potassium phosphate buffer 
containing 5 mM EDTA (KPE buffer; pH=7.5) and left on ice for 5 minutes prior to centrifugation 
at 10,000 x g for 5 minutes to prevent the oxidation of reduced glutathione (GSH). The remaining 
crude homogenate was further diluted with Tris-HCl to 20 volumes (v/v) with one aliquot stored for 
nNOS ELISA and the rest centrifuged at 10,000 x g for 10 minutes at 4°C and the supernatant was 
used for the determination of general oxidative status, zinc concentration, NO production, total 
NOx, and 3-nitrotyrosine with corresponding protein concentrations.  
 
General oxidative status  
Supernatant of neural tissue homogenate was diluted in 0.1 M Tris-HCl and incubated at a final 
concentration of 50 μM 2', 7'-dichlorodihydrofluorescein diacetate (DCFH-DA) containing 10 mM 
EDTA at 37
o
C for 30 minutes. Sample fluorescence was detected by POLARstar OPTIMA (BMG 
Labtechnologies) microplate reader with excitation and emission filters set at 485 nm and 520 nm. 
The general oxidative status for each sample was corrected for protein concentration and expressed 
as nM per mg protein. 
 
Reduced glutathione   
Reduced GSH concentrations were determined as described previously by Spiers et al., [3]. 
Trichloroacetic acid-treated hippocampal homogenate were added to positive (without N-
ethylmaleimide) and negative (with N-ethylmaleimide) reaction tubes for determinations of GSH. 
Redox quenched samples were plated on a 96-well plate and loaded with the fluorophore O-
phthaldialdehyde in a ratio of 7:1 sample to dye (v/v). Plates were incubated for 30 minutes in the 
dark and fluorescence was determined using a POLARstar OPTIMA (BMG Labtechnologies) with 
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excitation and emission filters set at 365 nm and 430 nm respectively. Sample concentrations were 
determined from a GSH standard curve and corrected for corresponding protein concentrations 
expressed as µM per mg protein. 
 
Zinc concentrations 
Zinc concentrations in the hippocampus were determined using a commercially available 
colorimetric kit (MAK032, Sigma Aldrich) and performed according to the manufacturer’s 
instructions. Unknown zinc concentrations in samples were determined from a standard curve and 
presented as nM per mg protein. 
 
Nitrosative status 
Hippocampal nitrosative status was assayed with 4-amino-5-methylamino-2′, 7′-difluorofluorescein 
diacetate (DAF-FM DA) according to method previously described in Chen et al., [33]. A 4 µM 
DAF-FM DA working solution was prepared in Tris-HCl (0.1 M, pH=7.4). Triplicates of diluted 
tissue supernatant were plated on a 96-well plate containing a final concentration of 2 µM of DAF-
FM DA. Samples were incubated for 60 minutes at room temperature and the highly fluorescent 
benzotriazole derivative of DAF-FM (DAF-FM T) fluorescence was measured by the POLARstar 
OPTIMA microplate reader (BMG Labtechnologies). Sample fluorescence was corrected for non-
specific sample and DAF-FM T auto-fluorescence monitored over the incubation period. Data were 
adjusted with corresponding protein concentrations and expressed as arbitrary fluorescence units 
per mg protein.  
 
Total NOx 
The total NO metabolites nitrate and nitrite, NOx, were measured in ultra-filtered supernatant using 
a commercially available total nitrate/nitrite colorimetric assay kit according to the manufacturer’s 
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instructions (Cayman Chemical Company, Ann Arbor, MI, USA). 30 µL of the hippocampal 
supernatant was ultra-filtered through a 10-kDa molecular weight cut-off filter using commercially 
available centrifugal devices (Pall Nanosep
®
, Cheltenham, Australia). Samples were corrected with 
corresponding protein concentrations and expressed as µM per mg of protein.  
 
Nitric oxide synthase 1 ELISA 
Hippocampal homogenates were lysed using the cell extraction buffer, provided by the NOS1 Rat 
SimpleStep ELISA
®
 kit (ab196266, Abcam
®
), containing phosphatase inhibitors and protease 
inhibitor aprotinin for 20 minutes at 4˚C. The homogenate was then centrifuged for 20 min at 
12,000 x g at 4˚C and the supernatant was collected. The levels of nNOS were determined 
according to the manufacturer’s instructions. Unknown concentrations were determined from 
standard equivalents using NOS1 rat lyophilized recombinant protein, corrected for corresponding 
protein concentrations, and presented as ng per mg protein. 
 
3-Nitrotyrosine  
A commercially available ELISA kit was used for the quantitative measurement of 3-NT modified 
proteins (ab116691, Abcam
®
) according to the manufacturer’s instructions. Unknown 
concentrations were determined from 3-NT bovine serum albumin standard equivalents, corrected 
for corresponding protein concentrations, and presented as ng per mg protein. 
 
 
 
mRNA expression 
Total RNA was extracted from the left hemispheric hippocampal tissues using the RNeasy mini kit 
(QIAGEN, Doncaster, Australia) and treated with deoxyribonuclease 1 (QIAGEN, Doncaster, 
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Australia) according to the manufacturer’s instructions. Extracted RNA was reverse transcribed into 
cDNA using the iScript
TM
 reverse transcription supermix (Bio-Rad Laboratories, Gladesville, 
Australia). Hippocampal mRNA levels were determined using the Taqman gene expression ‘assay-
on-demand
TM’ assays (Applied Biosystems, Foster City, CA). The probe sets used in this study are 
listed in Table 1. Each relative target gene expression to VIC-labelled glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH; Applied Biosystems, Foster City, CA) was determined using the formula 
2
-ΔCT 
where ΔCt = (Ct target gene – Ct GAPDH).  
 
Protein determination  
Protein was determined using commercially available Red 660
TM
 (G-Biosciences, St Louis, MO, 
USA) protein kit using bovine serum albumin as a standard.  
 
Statistical analysis  
Statistical analyses were performed using GraphPad Prism (Version 7.04, GraphPad Software Inc., 
San Diego, CA, USA). Data were first analyzed for normality using the Brown-Forsythe test. One-
way ANOVA with Fisher's least significant difference test was used to compare normally 
distributed data sets. A non-parametric Kruskal-Wallis with Dunn’s test was used for data sets with 
significantly different standard deviations. All comparisons were made against the unstressed group 
of animals. Data were presented as mean ± standard error of the mean (± SEM) and differences 
were considered statistically significant when p<0.05. 
 
Results 
Indicators of hypothalamic-pituitary-adrenal activity following restraint stress  
To demonstrate that exposure to restraint stress induces a significant stress response in the 
hippocampus over the course of this experiment, we measured the circulating corticosterone and 
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glucose in addition to expression of the hippocampal glucocorticoid receptor (Tab. 2). Despite the 
long duration of stress exposure, plasma corticosterone concentrations were significantly elevated 
following restraint stress [F(3, 28) = 4.267, p=0.0133]. Fisher’s post-test analysis indicated that 
corticosterone increased by approximately 3-fold above unstressed animals at 1 day (p<0.05), 2 
days (p<0.01), and 3 days (p<0.05) of stress exposure. Stress also increased circulating plasma 
glucose [F(3, 28) = 3.938, p=0.0184] concentrations at 1 day (p<0.01), 2 days (p<0.01), and 3 days 
(p<0.05). Furthermore, there were strong decreases in hippocampal glucocorticoid [F(3, 28) = 8.724, 
p=0.0003] receptor expression with post-test analysis showing significant reductions following 1 
day (p<0.001), 2 days (p<0.01), and 3 days (p<0.05) of restraint stress.  
 
Hippocampal redox status and mRNA expression of Nrf2 and its downstream targets 
Repeated restraint stress [F(3, 27)=2.98, p=0.049] significantly increased DCF fluorescence in 
hippocampal tissue (Fig. 1A). Post-test analysis revealed that this reached statistical significance 
after 2 days of restraint stress (p<0.01). Furthermore, Figure 1B demonstrated that exposure to 
restraint stress decreased antioxidant GSH concentrations by approximately 20% across all time-
points measured [F(3, 28)=4.492, p=0.0107]. Post-test analysis showed restraint significantly 
decreased GSH at 1 day (p<0.05), 2 days, and 3 days (p<0.01) of stress exposure. Together, these 
indications of oxidative stress in the hippocampus following stress led us to examine the master 
redox regulatory pathway governed by the transcription factor, Nrf2. Stress treatment [F(3, 28)=2.958, 
p=0.04947] was effective at increasing Nrf2 mRNA expression following two episodes of six hour 
restraint (p<0.01) (Fig. 2A). Furthermore, stress treatment [F(3, 28)=8.959, p=0.0003] induced a 
strong but transient reduction in expression of Keap1 at day 1 (p<0.001) that was no longer 
observed at 2 and 3 days of repeated restraint (Fig. 2B). Figure 2C shows effects of stress treatment 
on Nqo1 expression [F(3, 28)=4.553, p=0.0101] with post-test analysis indicating significant increases 
at 1 day and 2 days (p<0.01) of stress exposure. Furthermore, exposure to stress significantly 
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increased both Hmox1 [F(3, 28)=3.032, p=0.0458] and Hmox2 [F(3, 28)=3.515, p=0.028] mRNA levels 
occurring at 1 (p<0.05) and 2 (p<0.01) days of stress (Fig. 2D & 2E).  
 
Hippocampal zinc homeostasis following acute and repeated stress 
Figure 3A shows the effects of repeated restraint stress on metallothionein 1a (Mt1a) mRNA 
expression analyzed by a non-parametric Kruskal-Wallis test (p=0.0053). The Dunn’s post-test 
analysis revealed a significant increase in Mt1a mRNA at 1 (p<0.001) and 2 (p<0.05) days of stress 
exposure. Furthermore, analysis revealed significant effects of stress treatment [F(3, 28)=2.982, 
p=0.0482] on mRNA expression of the brain-specific metallothionein isoform, Mt3, in the 
hippocampus (Fig. 3B). Post-test analysis indicated the increase in Mt3 mRNA reached significance 
at 3 days (p<0.01) of repeated stress when compared to unstressed animals. Figure 3C demonstrates 
significant changes in hippocampal zinc concentrations following stress treatment [F(3, 27)=25.72, 
p<0.0001]. Fisher’s post-test showed significant increases in hippocampal zinc concentrations at 1 
day (p<0.001) followed by a decrease at 2 days (p<0.05) of restraint stress when compared to 
unstressed animals. Analysis of the hippocampal mRNA levels of zinc importer, Zip14 (Slc39a14), 
demonstrated a significant treatment effect [F(3, 28)=5.424, p=0.0045] with a transient decrease 
compared to unstressed animals at day 1 (p<0.01) that was no longer observed at 2 and 3 days of 
repeated stress (Fig. 3D).  
 
 
 
Hippocampal nitrergic activity and mRNA expression of nitric oxide producing enzymes 
Figure 4A shows the effects of stress treatment [F(3, 27)=14.11, p<0.0001] on the overall 
hippocampal DAF-FM T formation. Fisher’s post-test indicated DAF-FM T formation increased 
relative to unstressed animals at 1 and 2 days (p<0.001) of stress exposure. The stable metabolites 
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of NO, NOx, increased following stress treatment [F(3, 28)=2.982, p=0.0482] with post-test analysis 
indicating significance at 1 day (p<0.01) of restraint stress (Fig. 4B). A Kruskal-Wallis test 
(p=0.0043) with Dunn’s post-test demonstrated a significant increase in hippocampal 3-
nitrotyrosine formation of approximately 45% and 50% at 2 and 3 days (p<0.05) of repeated 
restraint stress respectively (Fig. 4C).   
To further examined the changes observed in the hippocampal nitrergic system, mRNA levels for 
the neuronal and inducible NOS isoforms in addition to Nos1ap and Xdh were measured. Analysis 
of hippocampal nNOS mRNA [F(3, 28)=7.484, p=0.0008] revealed a significant treatment effect on 
the gene expression of Nos1 (Fig. 5A). Post-test analysis indicated significantly decreased Nos1 
mRNA on 1 (p<0.001), 2 (p<0.001), and 3 (p<0.05) days of stress exposure. This decrease was also 
observed in NOS1 protein [F(3, 26)=8.681, p=0.0004] on 1 (p<0.001), 2 (p<0.001), and 3 (p<0.05) 
days of stress exposure (Fig. 5B). Interestingly, stress exposure induced progressive increases in 
Nos1ap mRNA [F(3, 28)=6.041, p=0.0026], becoming significantly upregulated at 2 days (p<0.05) 
and 3 days (p<0.001) of repeated restraint (Fig. 5C). Figure 5D highlights the changes in 
hippocampal iNOS mRNA levels following stress treatment analyzed using a non-parametric 
Kruskal-Wallis test (p=0.0012). Dunn’s post-test analysis demonstrated significant increases in 
iNOS expression relative to unstressed animals at 1 (p<0.05), 2 (p<0.001), and 3 (p<0.01) days of 
stress exposure in the hippocampus. Relative expression of Xdh was upregulated following 
treatment in the hippocampus [F(3, 28)=4.493, p=0.0107] with post-test analysis indicating significant 
increases following 1 (p<0.05), 2 (p<0.01), and 3 (p<0.05) days of restraint stress (Fig. 5E).  
 
Hippocampal mRNA expression of cytokines and neuroinflammatory markers  
Hippocampal tumor necrosis factor-alpha (Tnfα) expression decreased following stress treatment 
[F(3, 28)=3.077, p=0.0437] for 2 (p<0.05) and 3 (p<0.01) days (Fig. 6A). Moreover, expression of the 
Tnfα-converting enzyme, Adam17 (also known as TACE), was strongly downregulated following 
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stress [F(3, 28)=7.228, p=0.001] at all stress timepoints (p<0.001) (Fig. 6B). Conversely, two other 
pro-inflammatory cytokines demonstrated an increased expression profile following stress. 
Exposure to stress [F(3, 28)=3.194, p=0.0387] increased hippocampal Il1b mRNA levels after 2 days 
(p<0.05) (Fig. 6C) whilst Il6 mRNA, analyzed by a non-parametric Kruskal-Wallis test (p=0.0358) 
with Dunn’s post-test, increased following 3 days (p<0.01) of repeated stress exposure (Fig. 6D). 
Furthermore, Figure 6E shows a delayed increase in expression of the glucocorticoid-sensitive NF-
κB inhibitor alpha following repeated stress [F(3, 28)=3.199, p=0.0385] for 3 days (p<0.01) when 
compared to unstressed controls. The pro-inflammatory cytokine and a glucocorticoid counter-
regulator, Mif, was transiently upregulated at the mRNA level following a single stress [F(3, 
28)=5.08, p=0.0062] at day 1 (p<0.001) (Fig. 6F). There was also a significant effect of stress 
treatment [F(3, 28)=4.244, p=0.0136] on Cd74 mRNA, coding for the transmembrane protein required 
for Mif-induced signal transduction, following 1 day (p<0.05) and 2 days (p<0.01) of restraint stress 
(Fig. 6G).  
 
Discussion  
This study characterized the oxidative/nitrosative and inflammatory response in the hippocampus of 
rats exposed to a sub-acute model of repeated restraint stress. While we observed a number of 
similarities with our previous studies demonstrating that the hippocampus undergoes a degree of 
recovery by upregulating protective antioxidants following an initial oxidative challenge, the 
present study also indicates that this response may be inadequate with longer stress durations and 
repeated exposures. Moreover, the hippocampal nitrergic system appears to be principally driven by 
the inducible isoform, with concurrent upregulation of Xdh, resulting in accumulation of 
nitrotyrosinated proteins with repeated stress exposure.  
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To confirm the effectiveness of restraint stress over the duration of the experiment, we measured 
plasma corticosterone and glucose levels in addition to hippocampal glucocorticoid receptor 
(Nr3c1) expression. Corticosterone concentrations increased approximately 3-fold and plasma 
glucose concentrations increased approximately 30% in all restraint-stressed groups and were in 
agreement with previously published values [37]. There was also a robust downregulation of 
hippocampal glucocorticoid receptors that ranged between 20-40% compared to unstressed animals. 
Decreased expression of this receptor has been well documented in the hippocampus following 
exposure to stress due to the strong negative feedback exerted by this region. This is in agreement 
with Nishimura and colleagues [38] who observed similar downregulations of glucocorticoid 
receptors when stress was applied during the light cycle.   
 
We have previously observed acute stress cause an initial oxidative insult in the hippocampus 
within 1 hour of stress application with subsequent recovery towards baseline values within 2 hours. 
This change in oxidative state appeared to be partially mediated by glucocorticoids as 
pharmacological blockade of the glucocorticoid receptor with RU-486 attenuated this effect [3]. 
Moreover, recovery in the hippocampus relied on glutathione cycling to replenish the reduced form 
of glutathione. In the present study, we observed a similar recovery in oxidative state following a 
single stress with only minor increases after repeated exposures. However, in contrast to our 
previous study, the reduced form of glutathione was significantly lower following restraint, with 
repeated exposures exacerbating this effect. Interestingly, the application of stress in this 
experiment encompasses the circadian peak in glutathione and precedes peaks in glutathione 
reductase/peroxidase activity which may account for the absence of GSH replenishment observed 
here [39-42].  
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This relative paucity of non-enzymatic glutathione protection led us to question whether there 
would be transcriptional activation of antioxidants regulated by Nrf2 to counteract this redox 
imbalance. Relative mRNA levels of Nrf2 showed low levels of induction above unstressed animals 
and then, only after repeated exposure to restraint. This was similar to our previous study which 
demonstrated Nrf2 initially decreased before returning to unstressed levels after 4 hours of acute 
stress exposure [3]. Moreover, Khalaj and colleagues [43] demonstrated that Nrf2 expression peaks 
at 2 hours of stress exposure before returning to baseline levels at the 6 hours of stress used in this 
study. However, here we have shown that Keap1, the inhibitory regulator of Nrf2 is downregulated 
following a single stress exposure, indicating that changes in the sensitivity of Nrf2 activity may be 
more strongly influenced by Keap1 inhibition than transcriptional regulation. The Nrf2-ARE 
pathway plays a critical role in regulating the expression of genes encoding for phase II detoxifying 
enzymes. In the present study, we have determined levels of downstream antioxidants regulated by 
Nrf2 including Nqo1 and Hmox1 in addition to the constitutively-expressed and glucocorticoid-
responsive Hmox2. Recent evidence has suggested the enzymatic by-product of Hmox1/2, bilirubin, 
acts in an antioxidant capacity to curtail the upregulation of iNOS while leaving other pro-
inflammatory responses intact [44]. Interestingly, all three antioxidant enzymes showed 
significantly increased expression after both single and repeated stress exposure. However, it is 
important to note that following a third day of repeated restraint, expression of each of these 
antioxidants no longer differed from unstressed animals, despite still exhibiting significantly lower 
reduced glutathione. 
 
The cysteine-rich metallothioneins also play an important role as antioxidants in mediating 
intracellular zinc trafficking, with zinc itself becoming well recognized as a component of the 
antioxidant network and involvement in redox-regulated signaling. Several studies have previously 
demonstrated that the antioxidant metallothioneins are extremely sensitive to numerous 
16 
 
physiological stimuli including metal ion dys-homeostasis, redox imbalance, and glucocorticoids 
[45-47]. Work from our laboratory has demonstrated the time-course of metallothionein mRNA 
upregulation following acute restraint, indicating a progressive and significant increase in the 
hippocampus beginning two hours after the onset of stress [3]. Interestingly, results from this 
present study indicate that metallothionein induction after a single stress is limited to the Mt1a 
isoform principally associated with astrocytes, with subsequent stress exposures resulting in a 
habituated response. However, expression of the Mt3 isoform found in both neurons and astrocytes 
remains largely unchanged until 3 days of repeated restraint. Furthermore, hippocampal zinc 
concentrations show highly plastic changes in response to restraint, increasing 25% after a single 
stress exposure, decreasing after a second, and normalizing relative to unstressed animals following 
3 days of repeated stress. This could be due in part to the downregulation of the zinc importer, 
Zip14, as a result of acute stress exposure. Decreased expression of this transporter after the initial 
acute stress response may induce a deficit in hippocampal zinc that is corrected over the following 
days. Takeda and colleagues [48] have previously demonstrated acute increases in hippocampal 
zinc, both in vivo following stress and in vitro using hippocampal slice preparations following 
glucocorticoid exposure. However, it is important to note that the effects of stress on zinc 
homeostasis are complicated by the transcriptional and non-genomic effects of glucocorticoids, with 
slice preparations indicating acute synaptic effects may be driven by non-genomic mechanisms 
while buffering mechanisms, such as the metallothioneins, rely on transcriptional activation. The 
assay used for zinc determination in this present study measures the total tissue levels of zinc and is 
not capable of differentiating between the labile and protein bound pools. However, Dou and 
colleagues [49] have shown 7 days of psychological stress increases hippocampal labile free zinc 
while decreasing the total zinc, an effect suggested to be caused by downregulation of zinc 
transporters. Moreover, the authors postulate that a pro-oxidative cellular environment potentiates 
additional zinc release from protein-bound pools. This disruption in zinc partitioning may represent 
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an important mechanism differentiating the transition from acute to chronic stress and the 
subsequent development of pathologies. 
 
Reactive nitrogen species, including NO, also contribute to the cellular pro-oxidative tone suggested 
to facilitate zinc mobilization under stressful conditions. Indeed, zinc and NO share a number of 
highly specific biological functions, including distinct sensor regions in the Keap1 protein, with 
increases in either molecule impairing Keap1-induced ubiquitination of Nrf2 and subsequently 
increasing Nrf2 transcriptional activity [5]. Previous experiments in our laboratory have 
demonstrated stress-induced increases in hippocampal NO production switch from calcium-
dependent NOS isoforms to the calcium-independent inducible isoform with longer durations of 
acute stress exposure [33]. This was accompanied by subtle decreases in expression of Nos1 and 
highly potentiated expression of Nos2 of approximately 10-fold. In this present study, while stress 
induced similar directional changes in Nos1/2 expression, the magnitude of these changes presented 
quite differently. There was a strong downregulation of Nos1 mRNA expression and decreased 
NOS1 protein with a variable upregulation of Nos2 to approximately 3-fold. This is likely due to 
the application of stress in the light cycle when NOS expression is lowest as it approaches the 
circadian nadir [50, 51]. However, together with our previous acute stress study, these findings 
differ with earlier observations of upregulated hippocampal nNOS following sub-acute and chronic 
stress which may indicate a critical change in NOS signaling occurs early in models of chronic 
stress exposure [30-32]. Notably, we observed progressive stress-induced increases in Nos1ap 
mRNA, an adapter protein that has more recently been suggested to mediate NMDAR-driven nNOS 
signaling with NOS1AP overexpression generating an anxiogenic phenotype by facilitating nNOS-
dexras1 coupling to mediate downstream iron homeostasis via divalent metal transporter 1 [20, 52]. 
Importantly, in the development of chronic stress where increased nNOS has been reported, 
concurrent increases in NOS1AP would potentiate excitatory NMDAR-nNOS-NOS1AP signaling 
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and facilitate neurotoxicity induced by iron dys-homeostatis [53]. We have also demonstrated 
hippocampal 3-NT, a downstream marker of increased NO/superoxide-derived peroxynitrite, 
appears to accumulate with repeated stress exposure and this occurs in the apparent absence of 
increased NO metabolism. Whilst this may simply be indicative of the different temporal dynamics 
of these markers, it is interesting to note that the Xdh enzyme, capable of producing superoxide 
anion and recycling NO from NOx metabolites, was over the duration of the experiment [27, 54]. 
However, expression of Xdh can also be induced by several inflammatory cytokines including 
TNF-α and IL-1β, and the XDH protein itself can produce other reactive species in addition to NO 
[27, 55, 56]. 
 
The induction of Nos2 and the accumulation of 3-NT suggest stress induces a pro-oxidative state in 
the hippocampus that likely further favors pro-inflammatory responses. The observation of a stress-
induced neuroinflammatory response following high concentrations of anti-inflammatory 
glucocorticoids has been an area of intense scrutiny [reviewed thoroughly in Frank et al., [57, 58]].  
Here, we show repeated stress exposure progressively induced decreases in Tnf and increases in 
Il1b, Il6, and Nfkbia mRNA expression. It is important to note that each marker likely undergoes an 
individual acute stress-induced profile within each 6-hour exposure. For example, our previous 
study indicated Il1b expression was reduced nearly 50% and Bottero and colleagues [59] have 
demonstrated Nfkbia expression exhibits peak stress-induced expression similarly after 1 hour of 
stress exposure, with both exhibiting comparable recovery by 4 and 6 hours of stress exposure 
respectively. It has been suggested that increased levels of Il1b and Il6 originate from the 
sensitization of microglia to stress hormones, with Il6 in particular exhibiting resistance to the anti-
inflammatory effects of glucocorticoids and capable of exerting positive feed forward expression to 
further potentiate hypothalamic-pituitary-adrenal axis activity [60-63]. Conversely, Tnf is 
particularly susceptible to the effects of glucocorticoids and has been well documented to decrease 
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with stress exposure [64, 65]. This susceptibility may be due to glucocorticoid-induced 
downregulation of both Tnf and Adam17/TACE, resulting in dual inhibitory control of this pro-
inflammatory mediator [66, 67]. Another candidate of particular interest is the pro-inflammatory 
cytokine, Mif, known to potentiate a pro-inflammatory response in immune cells, including 
microglia, stimulated by glucocorticoids [68, 69]. Here, we show stress increases hippocampal 
expression of Mif acutely, in addition to increasing expression of the cell surface receptor, Cd74, 
responsible for Mif signal transduction and assisting in assembly of Cd74-MHC class II complexes 
[70]. However, this increase in Cd74 is likely transient and indicative of increased immune 
surveillance, as decreases in hippocampal Cd74 expression have been observed following 7 days of 
immobilization stress, marking the beginning of glucocorticoid-induced immunosuppression in the 
hippocampus [71].  
 
In summary, sub-acute stress causes a progressive increase in specific neuroinflammatory 
cytokines, including Il6 and Mif, capable of further potentiating the effects of glucocorticoids in the 
hippocampus. This occurs concurrently with a switch from constitutive to inducible NOS signaling 
and increased expression of Xdh, resulting in an accumulation of nitrotyrosinated proteins, zinc 
dys-homeostasis, and reductions in GSH. While there appears to be some protection afforded by the 
metallothionein antioxidants and members of the Nrf2 pathway, induction of these antioxidants is 
transient, relatively low, and does not offset the loss of GSH or accumulation of 3-NT. Thus, the 
loss of antioxidant protection may be one of the first demarcations occurring between acute and 
chronic stress in the hippocampus that ultimately leads to stress-induced pathophysiology. 
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Figure 1. The effects of acute (1 Day, single 6 h) and repeated (2 and 3 Days, 6 h/day) restraint 
stress on hippocampal redox status indicated by (A) dichlorofluorescein (DCF) formation and 
(B) reduced glutathione (GSH) concentration compared to unstressed rats (n=8/group). Data 
were analyzed using one-way ANOVA with Fisher’s LSD test and expressed as mean ± SEM, 
*p<0.05, ** p<0.01. 
 
Figure 2. The effects of acute (1 Day, single 6 h) and repeated (2 and 3 Days, 6 h/day) restraint 
stress on hippocampal (A) nuclear factor (erythroid-derived 2)-like 2 (Nfe2l2; also known as Nrf2), 
(B) Kelch-like ECH-associated protein 1 (Keap1), (C) NAD(P)H dehydrogenase, quinone 1 
(Nqo1), (D) heme oxygenase 1 (Hmox1), and (E) heme oxygenase 2 (Hmox2) mRNA expression 
compared to unstressed rats (n=8/group). Data were analyzed using one-way ANOVA with Fisher’s 
LSD test and expressed as mean ± SEM, *p<0.05, ** p<0.01. 
 
Figure 3. The effects of acute (1 Day, single 6 h) and repeated (2 and 3 Days, 6 h/day) restraint 
stress on hippocampal (A) metallothionein 1a (Mt1a), (B) metallothionein 3 (Mt3), (C) zinc 
concentrations, and (D) solute carrier family 39 member 14 (Slc39a14; also known as Zip14) 
mRNA expression compared to unstressed rats (n=8/group). Results in A were analyzed using non-
parametric Kruskal-Wallis test with Dunn’s post-test; B, C, and D were analyzed using one-way 
ANOVA with Fisher’s LSD test. Data are expressed as mean ± SEM, *p<0.05, ** p<0.01, 
***p<0.001. 
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Figure 4. The effects of acute (1 Day, single 6 h) and repeated (2 and 3 Days, 6 h/day) restraint 
stress on hippocampal (A) nitrosative status measured by the benzotriazole derivative of 4-amino-5-
methylamino-2′,7′-difluorofluorescein (DAF-FMT) formation, (B) total nitrite and nitrate (NOx), 
and (C) 3-nitrotyrosine concentration compared to unstressed rats (n=8/group). Results in A and B 
were analyzed using one-way ANOVA with Fisher’s LSD test; C was analyzed using non-
parametric Kruskal-Wallis test with Dunn’s post-test. Data are expressed as mean ± SEM, ** 
p<0.01, ***p<0.001. 
 
Figure 5. The effects of acute (1 Day, single 6 h) and repeated (2 and 3 Days, 6 h/day) restraint 
stress on hippocampal (A) neuronal nitric oxide synthase (Nos1) mRNA expression and (B) NOS1 
protein concentration compared to unstressed rats (n=6-8/group). The effects of acute and repeated 
restraint stress on hippocampal (C) nitric oxide synthase 1 adaptor protein (Nos1ap), (D) inducible 
nitric oxide synthase (Nos2), and (E) xanthine dehydrogenase (Xdh) mRNA expression compared 
to unstressed rats (n=8/group). Results in A, B, C, and E were analyzed using one-way ANOVA 
with Fisher’s LSD test; D was analyzed using non-parametric Kruskal-Wallis test with Dunn’s post-
test. Data are expressed as mean ± SEM, *p<0.05, ** p<0.01, ***p<0.001. 
 
Figure 6. The effects of acute (1 Day, single 6 h) and repeated (2 and 3 Days, 6 h/day) restraint 
stress on hippocampal (A) tumor necrosis factor (Tnf), (B) ADAM metallopeptidase domain 17 
(Adam17), (C) interleukin-1β (Il1b), (D) interleukin-6 (Il6), (E) nuclear factor of kappa light 
polypeptide gene enhancer in B-cells inhibitor, alpha (Nfkbia), (F) macrophage migration inhibitory 
factor (Mif), and (G) Cd74 molecule, major histocompatibility complex, class II invariant chain 
(Cd74) mRNA expression compared to unstressed rats (n=8/group). Results in A, B, C, E, F, G 
were analyzed using one-way ANOVA with Fisher’s LSD test; D was analyzed using non-
parametric Kruskal-Wallis test with Dunn’s post-test. Data are expressed as mean ± SEM, *p<0.05, 
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** p<0.01, ***p<0.001. 
 
Table 1. List of Taqman gene expression assays. 
 
Gene name Assay ID (in Applied Biosystems) 
Nr3c1 Rn00561369_m1 
Nfe2l2 Rn00477784_m1 
Keap1 Rn01448229_m1 
Nqo1 Rn00566528_m1 
Hmox1 Rn01536933_m1 
Hmox2 Rn00577761_m1 
Mt1a Rn00821759_g1 
Mt3 Rn00588658_g1 
Slc39a14 Rn01468336_m1 
Nos1 Rn00583793_m1 
Nos1ap Rn00594475_m1 
Nos2 Rn00561646_m1 
Xdh Rn00567654_m1 
Tnf Rn01525859_g1 
Adam17 Rn00571880_m1 
Il1b Rn00580432_m1 
Il6 Rn01410330_m1 
Nfkbia Rn01473657_g1 
Mif Rn00821234_g1 
Cd74 Rn00565062_m1 
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Table 2. The effects of acute (1 Day, single time of 6 h) and repeated (2 and 3 Days, 6 h/day) 
restraint stress on plasma corticosterone and glucose concentration, in addition to hippocampal 
glucocorticoid receptor (Nr3c1) mRNA expression compared to unstressed rats (n=8/group). 
 
 
 
Unstressed 
Control 
Stress exposure 
1 Day 2 Day 3 Day 
Plasma corticosterone 
(ng/mL) 
112.7 ± 30.72 321.2 ± 57.04* 389.5 ± 73.87** 317.1 ± 61.32* 
Plasma glucose 
(mmol/L) 
9.45 ± 0.46 12.46 ± 0.50** 12.24 ± 0.87** 12.09 ± 0.91* 
Hippocampal Nr3c1 
mRNA levels 
1.01 ± 0.05 0.59 ± 0.03*** 0.71 ± 0.06** 0.81 ± 0.09* 
Data were analyzed using one-way ANOVA with Fisher’s LSD test expressed as mean ± SEM, 
*p<0.05, ** p<0.01, ***p<0.001. 
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Highlights  
o Sub-acute stress induces hippocampal oxidative stress and antioxidant expression  
o Stress acutely disrupts hippocampal zinc homeostasis and metallothionein expression 
o Nitrergic signaling relies on increased expression of inducible NOS during stress 
o Repeated stress progressively increases hippocampal protein nitrotyrosination 
o Sub-acute stress causes a pro-inflammatory phenotype in the hippocampus 
 
